1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Abortion, Recurrent in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duran Erdolu, M; Erdamar, H; Eser, A; Inegol Gumus, I; Kaygusuz, I; Ozturk Turhan, N; Simavli, SA; Usluogullari, B; Yigitoglu, R; Yildirim, M | 1 |
| Bremme, K; Frostegård, J; Wramsby, ML; Wu, R | 1 |
| Adams, DM; Peaceman, AM; Silver, RK | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Abortion, Recurrent
| Article | Year |
|---|---|
Understanding prostaglandin metabolites and platelet-activating factor in the pathophysiology and treatment of the antiphospholipid syndrome.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; Female; Humans; Platelet Activating Factor; Pregnancy; Prostaglandin Antagonists; Prostaglandins | 1995 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Abortion, Recurrent
| Article | Year |
|---|---|
Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients.
Topics: Abortion, Habitual; Adult; Carboxypeptidase B2; Case-Control Studies; Female; Humans; Platelet Activating Factor; Prospective Studies | 2016 |
Antibodies against platelet-activating factor and platelet-activating factor-like lipids are raised in women with primary recurrent abortion.
Topics: Abortion, Habitual; Adult; Antibodies; Cardiolipins; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lipoproteins, LDL; Lysophosphatidylcholines; Oxidation-Reduction; Phosphatidylcholines; Platelet Activating Factor; Pregnancy | 2003 |